U.S. Blocks U.N. Pandemic Preparedness Declaration

The United States blocked a United Nations declaration on preparing for future pandemics on 25 September 2026. The objection came at a General Assembly high-level meeting on pandemic prevention, preparedness and response, part of its 81st session. That meeting had been due to adopt a political declaration on the same topic. The Guardian

Italy also rejected the document. Most member nations spoke in support of it. Without consensus, adoption failed. The New York Times

The draft called for stronger preparedness, coordination, financing, laboratory capacity, and access to medicines and vaccines. Laboratory capacity means the labs, staff and systems able to detect and track disease. The text repeated an intent to scale up preparedness and improve coordination within countries. The meeting had been convened to approve a concise and action-oriented declaration already agreed through negotiations between governments.

Declarations of this kind do not impose legally binding requirements. They cannot be enforced like a treaty. They serve as a sign of commitment and intent.

CDC Director Dr Erica Schwartz set out the U.S. position. She said critical issues remained unresolved. She cited "the inclusion of divisive ideologies that lack definitional consensus" and references to WHO-led negotiations over fair sharing of vaccines and drugs. The U.S. delegate said the United States was "not in a position" to support the text.

The European Union delegate said the EU was "fully and unreservedly committed" to the overarching objective. But it had "red lines" on intellectual property references, including whether technology transfer should be voluntary or mandated. Intellectual property here means legal rights over inventions such as vaccines. That divide was stated openly in the chamber, alongside the U.S. objection.

The United States withdrew from the World Health Organization shortly after President Trump took office. It had previously rejected amendments adopted in 2024 by World Health Organization members to its legally binding health rules. Reuters

A separate WHO-led pandemic agreement is on hold. Countries are still seeking agreement on pathogen access and benefit sharing. That is the bargain over vaccines and treatments in return for sharing data on emerging diseases. Think of it as a trade: early data on new germs in exchange for a share of the medicines made from that data.

Prof Lawrence Gostin, a global health law expert from Georgetown University, said the U.S. decision to block the declaration "severely weakens" the effort. He said the dissent signals a U.S. intention not to cooperate globally on health threats common to all nations.

The broader context here is procedural as well as substantive. Consensus adoption is the currency of General Assembly declarations. The text carries weight because no state objects. When objection blocks adoption, the declaration loses that particular form of authority even if most delegations support its content. Diplomats are left with a supported text that was not adopted.

In my view, readers should watch where the text goes next rather than treating non-adoption as the endpoint. A blocked declaration can be revised, put to a vote with recorded objections, or left as a statement of majority support without formal adoption. Each path has different diplomatic costs. Revision risks reopening settled paragraphs to satisfy objectors. A vote preserves the text but records division. Non-adoption preserves positions but weakens the signal of shared intent. None of those outcomes changes the legally nonbinding character of the instrument, but each would shape how the parallel WHO negotiation proceeds and how seriously capitals treat the next high-level review.